• ANJU SARAH MATHEWS Department of , Krupanidhi College of Pharmacy, Bengaluru, Karnataka, India.
  • SRESHI KUMARI Department of, Krupanidhi College of Pharmacy, Bengaluru, Karnataka, India.



Hypertension, Medication adherence, Clinical pharmacist, Pharmaceutical care, Patient education, Patient counseling, Intervention


Objective: The study objective was to analyze the effect of pharmacist interventions in improving blood pressure control.

Methods: The prospective interventional study was conducted on a population who were known hypertensive for more than 2 years. They were randomly categorized into two groups, interventional group and usual care group. Pharmaceutical care, involving telephonic follow-up, adherence analysis, patient education was given in the former group in a time interval of 2 months for about 12 months while the later was on regular therapeutical care only. Blood pressure was monitored in each follow-up. The difference in control of blood pressure was measured in terms of mm/Hg unit. The improvement in the measure from start and end of the study was analyzed within the group and between the groups.

Results: Lowered blood pressure was observed in both the groups in the end of study. But statistically significant difference was seen in interventional group compared to the other. Involvement of pharmacist led care helped in achievement of AHA goal.

Conclusions: Including clinical pharmacist in a health-care team can provide unerring therapeutic regimen to patients thereby their health-care outcome.


Download data is not yet available.


Brenda MM, Joseph JS, Eric JM. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy 2000;20:1384-9. doi: 10.1592/phco.20.17.1384.34891, PMID 11079287.

Ashfaq HM, Sidrah F, Mohammed EZ, Shireen S, Chandra NY. Role of clinical pharmacist in patients with diabetes and hypertension: A prospective study. World J Pharm Res 2019;8:842-58.

Brian JI, Daniel EB, Barry LC, Smith M, Polgreen LA, James PA. Evaluation of pharmacist’ work in a physician pharmacist collaborative model for the management of hypertension. Pharmacotherapy 2016;36:357-60. doi: 10.1002/phar.1727, PMID 26893135.

Ejaz C, Paul S, Donald RJ. The impact of interventions bypharmacists in community pharmacies on control of hypertension: A systematic review and meta-analysis of randomized controlled trials. Br J Clin Pharmacol 2014;78:1238-47. doi: 10.1111/bcp.12452, PMID 24966032.

Isabelle C, Jocelyne M, Jean-Pierre G, Alain M. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003;37:1186-93. doi: 10.1345/aph.1C267, PMID 12921497.

Venkatesh RK, Ravi VK. Study the impact of clinical pharmacist provided patient counseling on hypertension management in rural Indian population. Arch Pharm Pract 2013;4:28-34. doi: 10.4103/2045- 080X.111579.

Stefano O, Tenti M, Coronetti C. Physician-pharmacist collaborative practice and telehealth may transform hypertension management. J Hum Hyperten 2019;33:177-87.

de Lyra DP Jr., Marcellini PS, Pela IR. Effect of pharmaceutical care intervention on blood pressure of elderly outpatients with hypertension. Braz J Pharm Sci 2008;44:451-7.

McDonald M, Hertz RP, Unger AN, Lustik MB. Prevalence awareness and management of hypertension, dyslipidemia, and diabetes among united states adults aged 65 years and older. J Gerontol 2009;64:256-63.

Wal P, Wal A, Bhandari A, Pandey U, Rai AK. Pharmacist involvement in the patient care improves outcomes in hypertension patients. J Res Pharm Pract 2013;2:123-9. doi: 10.4103/2279-042X.122386, PMID 24991619.

Colvin NN, Mospan CM, Buxton JA, Waggett JD, Gillette C. Using Indian Health Service (IHS) counseling techniques in an Independent Community pharmacy to improve adherence rates among patients with diabetes, hypertension, or hyperlipidemia. J Am Pharm Assoc 2018;58:s59-63.e2. doi: 10.1016/j.japh.2018.04.024, PMID 29895481.

Morgado M, Rolo S, Castelo-Branco M. Pharmacist intervention program to enhance hypertension control: A randomized controlled trial. J Clin Pharm Ther 2011;33:132-40. doi: 10.1007/s11096-010- 9474-x, PMID 21365405.

Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen Intern Med 2005;20:1091-6. doi: 10.1111/j.1525-1497.2005.0226.x, PMID 16423096.

El Hajj MS, Mahfoud ZR, Al Suwaidi J, Alkhiyami D, Alasmar AR. Role of pharmacist in cardiovascular disease-related health promotion and in hypertension and dyslipidemia management: A cross sectional study in the state of Qatar. J Eval Clin Pract 2015;22:329-40. doi: 10.1111/jep.12477, PMID 26552842.

Charrois TL, McAlister FA, Cooney D, Lewanczuk R, Kolber MR, Campbell NR. Improving hypertension management through pharmacist prescribing; the rural Alberta clinical trial in optimizing hypertension (Rural RxACTION): Trial design and methods. Implement Sci 2011;6:94. doi: 10.1186/1748-5908-6-94, PMID 21834970.

Erhun WO, Agbani EO, Bolaji EE. Positive benefits of a pharmacist-managed hypertension clinic in Nigeria. Public Health 2005;119:792-8. doi: 10.1016/j.puhe.2004.11.009, PMID 15990127.



How to Cite

MATHEWS, A. S., and S. KUMARI. “IMPACT OF PHARMACIST LED HYPERTENSION MANAGEMENT”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 5, May 2022, pp. 23-26, doi:10.22159/ajpcr.2022.v15i5.43630.



Original Article(s)